SCADFILM and SCAD kick off the fourth annual SCAD AnimationFest Lacoste in France this week. School-run festivals are always ...

The share acquisition is the latest twist in a dispute between Alcon and fellow Aurion shareholder Deerfield Management over ...

Alcon has acquired a majority interest in Aurion Biotech, according to a press release. Aurion will operate as a separate ...

Aurion is developing AURN001, a clinical-stage allogeneic cell therapy asset, for corneal edema secondary to corneal ...

Inter Parfums, Inc. IPAR is flourishing in the fragrance industry, driven by robust brand momentum and a growing market share ...

Lacoste recently presented Lacoste LightClub ... the latest addition to the French sportswear company’s L003 franchise. The L003 Neo Shot features an updated design that is cleaner, more ...

Alcon said that its majority stake means that Aurion will have "broader R&D, regulatory, medical ophthalmic, and commercial ...

A first-time visit to Savannah, Ga., reveals the astonishing influence of SCAD, the Savannah College of Art and Design.

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed.

Eye care giant Alcon appears to have gained the upper hand in the ongoing power struggle with Aurion Biotech by securing a ...

Alcon Acquires Majority Interest in Aurion Biotech, Inc. to Advance Innovative Cell Therapy for Corneal Endothelial Disease ...